Developer docs
API playgroundTry for free, no card

Search company profiles

Metabiota

Full company profile

uuid0000nyf

Namestring
Metabiota
Legal namestring
Meta Biota
Websiteurl
metabiota.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Metabiota operates as a health and wellness content and affiliate marketing platform based at 535 Mission St, 14th Floor, San Francisco. The company publishes evidence-based editorial articles, scientific research reviews, and product analyses covering hormonal health, metabolism, nutrition, and global health topics including SARMs and supplement alternatives. Its primary distribution channel is metabiota.com, supported by a 30,000+ subscriber email newsletter and SEO-optimized organic search content. The business model is built on affiliate referrals — the platform reviews third-party dietary supplements (including products from Brutal Force, Rootana, Huel, and others) and earns commissions when readers purchase through embedded links to manufacturer websites. No direct-to-consumer products, paid subscription tiers, or enterprise services are disclosed.

The company's current operations are distinct from its historical identity. According to funding data and named leadership, Metabiota was previously a venture-backed epidemic intelligence and pandemic preparedness firm that raised approximately $41.2M between 2014 and 2018 from investors including Google Ventures, Capricorn Investment Group, Obvious Ventures, Pilot Growth Equity, Tao Capital Partners, and In-Q-Tel. Founder Nathan Wolfe and a leadership team including VPs of Product/Policy and Marketing were associated with that prior business. The present-day content platform is materially smaller in scope, headcount, and capital intensity than the legacy venture-backed entity, and the relationship between the two operations is not clarified in available source material.

The platform's competitive positioning rests on a horizontal content-marketing strategy targeting health-conscious consumers seeking supplement and nutrition guidance. It does not manufacture products, hold proprietary data assets, or operate in regulated health technology markets. Customer concentration is diffuse by design — the audience is a long-tail of individual consumers rather than enterprise accounts — and the primary commercial lever is affiliate conversion rate on supplement traffic.

Short descriptiontext

Metabiota is a San Francisco-based health and wellness content platform that publishes evidence-based articles and supplement reviews across hormonal health, metabolism, and nutrition, monetizing via affiliate referrals to third-party supplement brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health wellness content, supplement reviews, nutrition guidance, wellness articles, dietary supplements
Industry2 codes
1Microbiome Analytics, Sequencing & Bioinformatics Platforms
CodeHLAAAFAIPrimaryYes
2Microbiome & Metagenomics Services
CodeHLAGANAHPrimaryNo
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Health & Wellness Content
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Affiliate product recommendations
TypeAffiliate Referral
Description

The platform provides detailed reviews and recommendations for third-party health supplements (e.g., Brutal Force products, Rootana, Huel), likely earning affiliate commissions for qualified referrals. Reviews include specific product links and comparative analysis.

metabiota.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Metabiota operates a consumer-facing health and wellness content platform that publishes articles, scientific research reviews, and branded supplement product reviews. The site covers topics including SARMs alternatives, testosterone boosters, muscle gain supplements, weight loss aids, and women's health, monetizing through affiliate links to partner retailers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 30,000+ newsletter subscribers
Product overview1 text field

Metabiota is a health and wellness content platform that publishes editorial articles, scientific reviews, and product analyses. The company does not manufacture or sell its own products; instead, it provides informational content reviewing third-party supplements and health products. Its content covers categories including hormonal health, metabolism, nutrition, and global health topics.

Product and service1 record
1Metabiota Health & Wellness Content Platform
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Microbiome genomics and analytics platform offering sequencing-based pathogen and microbiome identification. Directly comparable to Metabiota's original positioning as a microbiome data analytics and human/animal health intelligence company.

TypeDirect peer
Description

Provides microbiome and metagenomics sequencing services and analytics for human and animal health research. Operates in the same microbiome analytics / specialty lab services category as Metabiota's original biotech thesis.

TypeBroad incumbent
Description

Large-scale synthetic biology and organism engineering platform with biosecurity and human health adjacencies. Comparable as a broader incumbent in the data-driven human/animal health analytics space Metabiota historically targeted.

TypeDirect peer
Description

Microbiome therapeutics and biomarker discovery company using microbiome analytics to inform drug development. Comparable to Metabiota's positioning at the intersection of microbiome data analytics and human health.

TypeEmerging player
Description

Consumer-facing microbiome testing and personalized nutrition insights platform. Comparable to Metabiota as an intersection of microbiome analytics with personalized health/wellness content for consumers.

TypeEmerging player
Description

Microbiome-derived therapeutics and supplements backed by clinical evidence. Comparable to Metabiota at the microbiome-to-consumer-health interface.

TypeDirect peer
Description

Independent, evidence-based supplement research and review platform for health-conscious consumers. Closest direct peer to Metabiota's current operating model as an affiliate-supported health research and supplement review content site.

TypeBroad incumbent
Description

Large-scale consumer health content platform monetized in part via affiliate and brand partnerships. Comparable to Metabiota as a health/wellness content site with affiliate-driven revenue across supplement and lifestyle categories.

TypeEmerging player
Description

DNA and microbiome-based personalized health reports with educational content. Comparable to Metabiota at the intersection of omics data analytics, supplements, and consumer health content.

TypeBroad incumbent
Description

Established consumer health information and education platform with extensive content coverage across conditions, supplements, and wellness. Comparable to Metabiota as a broad incumbent in evidence-based consumer health content.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Metabiota

Health & Wellness Contentmetabiota.com

Metabiota is a San Francisco-based health and wellness content platform that publishes evidence-based articles and supplement reviews across hormonal health, metabolism, and nutrition, monetizing via affiliate referrals to third-party supplement brands.

What Metabiota does

Metabiota operates as a health and wellness content and affiliate marketing platform based at 535 Mission St, 14th Floor, San Francisco. The company publishes evidence-based editorial articles, scientific research reviews, and product analyses covering hormonal health, metabolism, nutrition, and global health topics including SARMs and supplement alternatives. Its primary distribution channel is metabiota.com, supported by a 30,000+ subscriber email newsletter and SEO-optimized organic search content. The business model is built on affiliate referrals — the platform reviews third-party dietary supplements (including products from Brutal Force, Rootana, Huel, and others) and earns commissions when readers purchase through embedded links to manufacturer websites. No direct-to-consumer products, paid subscription tiers, or enterprise services are disclosed.

The company's current operations are distinct from its historical identity. According to funding data and named leadership, Metabiota was previously a venture-backed epidemic intelligence and pandemic preparedness firm that raised approximately $41.2M between 2014 and 2018 from investors including Google Ventures, Capricorn Investment Group, Obvious Ventures, Pilot Growth Equity, Tao Capital Partners, and In-Q-Tel. Founder Nathan Wolfe and a leadership team including VPs of Product/Policy and Marketing were associated with that prior business. The present-day content platform is materially smaller in scope, headcount, and capital intensity than the legacy venture-backed entity, and the relationship between the two operations is not clarified in available source material.

The platform's competitive positioning rests on a horizontal content-marketing strategy targeting health-conscious consumers seeking supplement and nutrition guidance. It does not manufacture products, hold proprietary data assets, or operate in regulated health technology markets. Customer concentration is diffuse by design — the audience is a long-tail of individual consumers rather than enterprise accounts — and the primary commercial lever is affiliate conversion rate on supplement traffic.

Metabiota firmographics

Firmographics
Name
Metabiota
Legal name
Meta Biota
Website
https://metabiota.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
51–100 employees
Short description
Metabiota is a San Francisco-based health and wellness content platform that publishes evidence-based articles and supplement reviews across hormonal health, metabolism, and nutrition, monetizing via affiliate referrals to third-party supplement brands.
Ownership category
akta.pro rank

Metabiota industry classification

Industry
Product category
Health & Wellness Content
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
akta.pro secondary industry
Microbiome & Metagenomics Services (HLAGANAH)

Keywords

  • Health wellness content
  • Supplement reviews
  • Nutrition guidance
  • Wellness articles
  • Dietary supplements

Where Metabiota is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Metabiota business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Affiliate product recommendations: The platform provides detailed reviews and recommendations for third-party health supplements (e.g., Brutal Force products, Rootana, Huel), likely earning affiliate commissions for qualified referrals. Reviews include specific product links and comparative analysis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Metabiota product offering

Product offering

Core offering

Metabiota operates a consumer-facing health and wellness content platform that publishes articles, scientific research reviews, and branded supplement product reviews. The site covers topics including SARMs alternatives, testosterone boosters, muscle gain supplements, weight loss aids, and women's health, monetizing through affiliate links to partner retailers.

Product overview

Metabiota is a health and wellness content platform that publishes editorial articles, scientific reviews, and product analyses. The company does not manufacture or sell its own products; instead, it provides informational content reviewing third-party supplements and health products. Its content covers categories including hormonal health, metabolism, nutrition, and global health topics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Metabiota Health & Wellness Content Platform

Quantifiable outcome

  • 30,000+ newsletter subscribers

Companies that use Metabiota

Customer profile

Segments1 record

Ideal customer profiles1 record

Metabiota technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Metabiota partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Metabiota competitors and assessment

Company assessment

Direct peers

  • CosmosID: Microbiome genomics and analytics platform offering sequencing-based pathogen and microbiome identification. Directly comparable to Metabiota's original positioning as a microbiome data analytics and human/animal health intelligence company.
  • Diversigen: Provides microbiome and metagenomics sequencing services and analytics for human and animal health research. Operates in the same microbiome analytics / specialty lab services category as Metabiota's original biotech thesis.
  • Second Genome: Microbiome therapeutics and biomarker discovery company using microbiome analytics to inform drug development. Comparable to Metabiota's positioning at the intersection of microbiome data analytics and human health.
  • Examine.com: Independent, evidence-based supplement research and review platform for health-conscious consumers. Closest direct peer to Metabiota's current operating model as an affiliate-supported health research and supplement review content site.

Broad incumbents

  • Ginkgo Bioworks: Large-scale synthetic biology and organism engineering platform with biosecurity and human health adjacencies. Comparable as a broader incumbent in the data-driven human/animal health analytics space Metabiota historically targeted.
  • Healthline: Large-scale consumer health content platform monetized in part via affiliate and brand partnerships. Comparable to Metabiota as a health/wellness content site with affiliate-driven revenue across supplement and lifestyle categories.
  • WebMD: Established consumer health information and education platform with extensive content coverage across conditions, supplements, and wellness. Comparable to Metabiota as a broad incumbent in evidence-based consumer health content.

Emerging players

  • Viome Life Sciences: Consumer-facing microbiome testing and personalized nutrition insights platform. Comparable to Metabiota as an intersection of microbiome analytics with personalized health/wellness content for consumers.
  • Pendulum Therapeutics: Microbiome-derived therapeutics and supplements backed by clinical evidence. Comparable to Metabiota at the microbiome-to-consumer-health interface.
  • SelfDecode: DNA and microbiome-based personalized health reports with educational content. Comparable to Metabiota at the intersection of omics data analytics, supplements, and consumer health content.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Metabiota social profiles

Digital presence

Metabiota financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Metabiota leadership team

Management profile

Number of profiles

Profiles7 records

Metabiota funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Metabiota M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metabiota

What does Metabiota do?

Metabiota operates a consumer-facing health and wellness content platform that publishes articles, scientific research reviews, and branded supplement product reviews. The site covers topics including SARMs alternatives, testosterone boosters, muscle gain supplements, weight loss aids, and women's health, monetizing through affiliate links to partner retailers.

Is Metabiota a public or private company?

Metabiota is a private company. It is classified as venture growth investor backed and is currently operating.

When was Metabiota founded?

Metabiota was founded in 2008. It employs 51 to 100 people.

Where is Metabiota based?

Metabiota is headquartered in San Francisco, United States, in the North America region.

How does Metabiota make money?

One revenue line is on record: affiliate product recommendations.

Who are Metabiota's main competitors?

Direct peers on record are CosmosID, Diversigen, Second Genome and Examine.com. Broad incumbents are Ginkgo Bioworks, Healthline and WebMD. Emerging players are Viome Life Sciences, Pendulum Therapeutics and SelfDecode.

Does Metabiota have an API?

No public API is recorded for Metabiota.

What industry is Metabiota in?

Metabiota's product category is Health & Wellness Content. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogQuantitative Biosciences Institute Appoints Brad Schneider, Ph.D., as Chief Operating OfficerThe Quantitative Biosciences Institute at UCSF appointed Brad Schneider as Chief Operating Officer. He brings over two decades of infectious disease and global health experience, previously leading Vaccines for Communities and Pinpoint Science. He will help build operational infrastructure for the institute's growth.SourcesecurityCyberCube partnered with Munich Re and Metabiota to understand the lessons both pandemic and cyber modelers could learnCyberCube released a report on lessons from pandemic and cyber modeling, highlighting that political decisions and public response affect both. It notes data scarcity hinders progress, with fewer than twelve major pandemics and few systemic cyber events. Addressing data collection limitations could improve model value for insurance markets.MIT Technology ReviewAI could help with the next pandemic—but not with this oneThe article argues that while AI companies like BlueDot and Metabiota provided early warnings for the coronavirus outbreak, their current utility is limited by data inconsistencies and a lack of diagnostic testing. It highlights that overhyping AI's capabilities risks diverting resources from proven interventions and notes significant obstacles in prediction accuracy and data sharing across borders.MarketplaceBig data predicted the coronavirus outbreak and where it would spreadCanadian startup BlueDot used artificial intelligence to predict the coronavirus outbreak and its spread to Thailand and Japan three weeks before official government announcements. The company notified the World Health Organization, which subsequently issued an early virus alert based on their data analysis. Other firms like Metabiota are also utilizing AI to assess epidemic risks and financial impacts for businesses.TechCrunchWant to know where epidemics are flaring up around the world? Metabiota has the tool for youSan Francisco-based startup Metabiota has released a free epidemic tracker tool that monitors publicly available outbreak data globally, positioning it as a public health service amid estimates that pandemics could cause $570 billion in annual economic losses. The company previously raised $30 million in financing for its premium disease-monitoring service, which offers more advanced analytics including pathogen models and risk analyses. Critics argue the free tool lacks the granularity needed for actual decision-making and functions primarily as a sales tool to upsell organizations to its paid platform.TechCrunchMetabiota Pulls In $30 Million In Funding To Help Predict The Global Spread Of DiseaseDisease outbreak prediction startup Metabiota has raised $30 million in Series A funding to scale its computer modeling offerings for government organizations and insurers globally. The new capital will be used to hire engineers and develop financial tools, such as epidemic insurance, to improve the speed of funds to affected countries during disease outbreaks. This round was led by growth equity firm RSTP with participation from Capricorn Healthcare, WP Global Partners, Industry Ventures, and Data Collective.